Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/the-new-england-journal-of-medicine/prostate-specific-antigen-testing-for-early-diagnosis-of-prostate-R2iLRZ63Ko
References (28)
-
R. Babaian, D. Johnston, William Naccarato, A. Ayala, Vijaya Bhadkamkar, H. Fritsche (2001)
The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy.The Journal of urology, 165 3
-
M. Terris (2000)
Extended field prostate biopsies: too much of a good thing?Urology, 55 4
-
R. Boer, F. Schröder (1999)
Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reductionThe Prostate, 40
-
R. Greenlee, Taylor Murray, Sherry Bolden, P. Wingo (2000)
Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 50
-
W. Catalona, A. Partin, K. Slawin, M. Brawer, R. Flanigan, Anup Patel, J. Richie, J. Dekernion, P. Walsh, P. Scardino, P. Lange, E. Subong, R. Parson, G. Gasior, K. Loveland, P. Southwick (1998)
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.JAMA, 279 19
-
B. Djavan, A. Zlotta, M. Remzi, K. Ghawidel, A. Basharkhah, Claude Schulman, M. Marberger (2000)
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.The Journal of urology, 163 4
-
F. Fowler, Lin Bin, M. Collins, Richard Roberts, J. Oesterling, John Wasson, Michael Barry (1998)
Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.The American journal of medicine, 104 6
-
R. Volk, S. Spann (2000)
Decision-aids for prostate cancer screening.The Journal of family practice, 49 5
-
J. Richie, W. Catalona, F. Ahmann, M. Hudson, P. Scardino, R. Flanigan, J. Dekernion, T. Ratliff, L. Kavoussi, Bruce Dalkin, W. Waters, M. Macfarlane, P. Southwick (1993)
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.Urology, 42 4
-
Robert Smith, A. Eschenbach, R. Wender, B. Levin, T. Byers, David Rothenberger, D. Brooks, W. Creasman, Carmel Cohen, C. Runowicz, D. Saslow, V. Cokkinides, H. Eyre (2001)
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer DetectionCA: A Cancer Journal for Clinicians, 51
-
D. Patel, P. White, A. Ward (2000)
A comparison of six commercial assays for total and free prostate specific antigen (PSA): the predictive value of the ratio of free to total PSABJU International, 85
-
P. Lodding, G. Aus, S. Bergdahl, R. Frosing, H. Lilja, C. Pihl, J. Hugosson (1998)
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.The Journal of urology, 159 3
-
P. Sershon, M. Barry, J. Oesterling (1994)
Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer.European urology, 25 4
-
W. Catalona, Christian Ramos, G. Carvalhal, Yan Yan (2000)
Lowering PSA cutoffs to enhance detection of curable prostate cancer.Urology, 55 6
-
Steven Oliver, David Gunnell, Jenny Donovan (2000)
Comparison of trends in prostate-cancer mortality in England and Wales and the USAThe Lancet, 355
-
R. Pruthi (2000)
Prostate specific antigen kinetics: A review of prostate specific antigen doubling times and half-lives in patients with treated and untreated prostate cancerThe Prostate Journal, 2
-
R. Babaian (2000)
Extended field prostate biopsy enhances cancer detection.Urology, 55 4
-
F. Labrie, B. Candas, A. Dupont, L. Cusan, José-luis Gomez, R. Suburu, P. Diamond, Jacques Lévesque, A. Bélanger (1999)
Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled TrialThe Prostate, 38
-
H. Carter, J. Pearson, J. Pearson (1999)
Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines.Urology, 54 5
-
M. Tchetgen, J. Song, M. Strawderman, S. Jacobsen, J. Oesterling (1996)
Ejaculation increases the serum prostate-specific antigen concentration.Urology, 47 4
-
J. Herschman, Deborah Smith, W. Catalona (1997)
Effect of ejaculation on serum total and free prostate-specific antigen concentrations.Urology, 50 2
-
H. Carter (2000)
A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: the only rational approach for men 50 years old and older.Urology, 55 6
-
T. Polascik, J. Oesterling, A. Partin (1999)
Prostate specific antigen: a decade of discovery--what we have learned and where we are going.The Journal of urology, 162 2
-
L. Klotz (1997)
PSAdynia and other PSA-related syndromes: a new epidemic--a case history and taxonomy.Urology, 50 6
-
F. Fowler, M. Collins, P. Albertsen, A. Zietman, D. Elliott, M. Barry (2000)
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.JAMA, 283 24
-
Evelyn Chan, D. Sulmasy (1998)
What should men know about prostate-specific antigen screening before giving informed consent?The American journal of medicine, 105 4
-
K. Ross, H. Carter, J. Pearson, H. Guess, H. Guess (2000)
Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.JAMA, 284 11
-
R. Nadler, P. Humphrey, Deborah Smith, W. Catalona, T. Ratliff (1995)
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.The Journal of urology, 154 2 Pt 1
- Publisher
- The New England Journal of Medicine
- Copyright
- Copyright © 2001 Massachusetts Medical Society. All rights reserved.
- ISSN
- 0028-4793
- eISSN
- 1533-4406
- DOI
- 10.1056/NEJM200105033441806
- pmid
- 11333995
- Publisher site
- See Article on Publisher Site
Abstract
ForewordThis Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.StageA 65-year-old man with no risk factors for prostate cancer except his age has a normal digital rectal examination. Should a prostate-specific–antigen (PSA) test be ordered? The Clinical Problem The introduction of PSA testing in 1987 resulted in an enormous increase in the reported incidence of prostate cancer in the United States. After peaking in 1992, the incidence fell, presumably owing to the identification of preexisting cases among men who had been tested. The rate of death from prostate cancer has risen and fallen over the same period for reasons that are unclear (Figure 1).1 Advocates of screening attribute . . .
Journal
The New England Journal of Medicine – The New England Journal of Medicine
Published: May 3, 2001